# Polymerase Capital

Polymerase Capital is an Asset Manager based in Seattle, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Seattle, United States
- **Region:** North America
- **Address:** Seattle, WA, United States
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** www.polymerase.capital
- **LinkedIn:** https://www.linkedin.com/company/polymerase-capital

## Regulatory record

- **Reports private funds:** No

## About

Polymerase Capital is a venture capital firm based in Seattle, Washington, founded in 2021. It focuses on investments in life science companies. The firm has made one investment to date.

## Sectors

- Biotechnology
- Healthcare Services

## People

- Thomas Chalberg — Founder and Managing Director

## Questions

### Who runs investment decisions at Polymerase Capital?

Founder and Managing Director Thomas Chalberg, Ph.D., leads investment decisions. Chalberg is a scientist by training with operating experience as co-founder of Genascence, a gene therapy company targeting osteoarthritis. His investment decisions are informed by this deep domain expertise in molecular biology and clinical development.

### Does Polymerase Capital participate in fund commitments or only direct deals?

The firm's known activity centers on direct venture investments rather than fund-of-fund commitments. Its co-investment relationships are deal-specific—partnering with entities like DeepWork Capital on Genascence—rather than LP positions in blind-pool venture funds.

## Related profiles

- [Polo Equity Partners](https://altss.com/profile/polo-equity-partners)
- [Pomifer Capital](https://altss.com/profile/pomifer-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/polymerase-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology